## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($133.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Contact Levi & Korsinsky by December 2, 2025 to Join Class Action Against Molina Healthcare, Inc. (MOH)**
- Source: KLAS 8 News Now | 20251130T113100 | Neutral | Relevance: 100%
- Levi & Korsinsky LLP is urging investors who suffered losses on their Molina Healthcare, Inc. (MOH) investment between February 5, 2025, and July 23, 2025, to join a class action lawsuit. The lawsuit alleges that Molina Healthcare made false statements and concealed material adverse facts regarding its medical cost trend assumptions and financial guidance for fiscal year 2025. Investors have until December 2, 2025, to contact the firm to learn about their rights to potentially recover losses.

**2. Investors who lost money on Molina Healthcare, Inc.(MOH) should contact The Gross Law Firm about pending Class Action - MOH**
- Source: Fox 59 | 20251201T134500 | Neutral | Relevance: 99%
- The Gross Law Firm has issued a notice for shareholders of Molina Healthcare, Inc. (NYSE: MOH) who incurred losses during the class period of February 5, 2025, to July 23, 2025. The firm is inviting affected investors to contact them regarding a pending class action lawsuit, alleging that Molina Healthcare made false statements and concealed material adverse facts about its medical cost trend assumptions and financial guidance. Shareholders have until December 2, 2025, to register for this class action to potentially be appointed as a lead plaintiff.

**3. MOH DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds Molina Healthcare, Inc. Investors to Join the Class Action Lawsuit**
- Source: CBS 42 | 20251201T070000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is reminding investors of Molina Healthcare, Inc. (MOH) to join a class action lawsuit filed against the company and its officers. The lawsuit alleges violations of federal securities laws for investors who purchased Molina securities between February 5, 2025, and July 23, 2025. The complaint claims that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance for fiscal year 2025.

**4. MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: PR Newswire | 20251201T090000 | Neutral | Relevance: 99%
- The Schall Law Firm is reminding investors of a class action lawsuit against Molina Healthcare, Inc. (NYSE: MOH) for alleged securities fraud. The lawsuit covers investors who purchased Molina's securities between February 5, 2025, and July 23, 2025, due to alleged false and misleading statements regarding the company's "medical cost trend assumptions" and potential financial guidance cuts. Investors who suffered losses are encouraged to contact the Schall Law Firm to participate in the lawsuit.

**5. Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH**
- Source: Stock Titan | 20251201T030200 | Neutral | Relevance: 99%
- Molina Healthcare, Inc. is being sued for securities law violations, with a class action alleging misleading statements about a "dislocation between premium rates and medical cost trend" impacting fiscal year 2025 guidance. The DJS Law Group is reminding shareholders of the class action, which covers the period from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025. Investors who purchased shares during this period are encouraged to contact the firm to discuss their rights.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 38.9% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.7B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -0.62 |
| Forward P/E | 10.4 |
| Current P/E | 10.3 |
| YoY Growth | -0.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.7% to -0.1% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). Below SMA200 (0.61x), long-term trend not supportive. MACD histogram positive (2.32), confirming momentum. RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.14% (CS: 58) | Neutral |
| RSI_14 | 43.9 | Neutral |
| MACD Histogram | 2.32 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 0.867x | Below |
| vs SMA200 | 0.611x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $145.97
- **Stop Loss:** $133.91 (8.3% risk)
- **Target:** $158.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $11,969.54
- **Portfolio %:** 11.97%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*